Dr. Eoin Flanagan talks with Dr. Tomas Kalincik about his paper, "Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis".
Show references: https://n.neurology.org/content/early/2021/10/05/WNL.0000000000012753
